The Valley Desk

ArticleHIV medicinePublished

Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Cooper Norcross Health, Cooper Medical School of Rowan University, with Rowan University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
HIV medicine
Published
Subject terms
Humans; HIV-1; HIV Infections; HIV Seropositivity; Reverse Transcriptase Inhibitors; Anti-HIV Agents; Viral Load; Drug Resistance, Viral; High-Throughput Nucleotide Sequencing; Human immunodeficiency virus (HIV); Antiretroviral therapy; Next Generation Sequencing
PubMed ID
37775947
PubMed Central ID
PMC10872720
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal